Ask questions across claims linked to experiments, exact results, limitations, and sources.Know what the science actually supports before you trust the answer.
Press Enter ↵ to search evidence
Explore by Goal
"Biology sees right and wrong as the same color in different light."
- Delia Owens
Quick Explanation
Copied
What you asked
“Meta-analysis: non-invasive neuromodulation pain in DPN — visualize effect sizes.”
With the research data you provided, there are no extractable neuromodulation effect sizes (e.g., pain-score mean/SD by arm, or standardized mean differences) to compute or plot an actual meta-analysis. The included papers are narrative reviews and do not supply study-level DPN neuromodulation effect data needed for effect-size synthesis. ()
()
Long Explanation
Non-invasive neuromodulation in DPN: effect-size meta-analysis is currently underdetermined
Your request requires study-level numeric outcomes (e.g., pain scale means/SDs by arm at follow-up, or change scores) to compute standardized effect sizes and then aggregate them.
The two provided sources are narrative reviews and do not include extractable numeric effect-size inputs for DPN non-invasive neuromodulation.
Therefore, I will not fabricate effect sizes.
Key evidence that effect-size inputs are missing:
()
()
What we can visualize from the provided data (diagnosis + burden + related neuropathic-pain prevalence)
Diagnostic emphasis: corneal confocal microscopy (CCM) as a noninvasive early screening tool
CCM and the list of diagnostic modalities come from the provided excerpt: ()
Treatment landscape (high-level): neuromodulation is mentioned, but effect sizes are not provided
High-level treatment coverage including neuromodulation is summarized in the provided excerpt: ()
Why I cannot plot “effect sizes” yet (and how to fix it)
Needed: trial-level numeric pain outcomes for non-invasive neuromodulation in DPN (or a defensible mapping if studies report mixed neuropathic populations).
Currently missing: the provided sources do not include arm-level mean/SD or sufficient statistics per study needed for standardized mean differences or response ratios.
Risk: if I guessed from narrative statements, the resulting “meta-analysis effect sizes” would be fabricated—scientifically invalid.
Most useful next step (BGPT full-text mining)
Let BGPT search full-text RCTs/non-invasive neuromodulation trials in DPN, extract numeric pain outcomes, then compute and plot a forest plot of standardized effect sizes (and heterogeneity/robustness checks).
Epistemic humility / limitations (important): These visualizations reflect only the provided extracted review excerpts (prevalence + diagnostic/treatment categories). They do not quantify non-invasive neuromodulation analgesic effect sizes because such data were not supplied in your research data. () ()
This code ingests BGPT-extracted full-text trial tables for DPN non-invasive neuromodulation, computes standardized pain-effect sizes per arm, pools them meta-analytically, and renders forest/funnel plots with heterogeneity metrics.
Get emailed when your analysis is done!
We'll email you the results when your analysis is finished.
Hypothesis Graveyard
Assuming a narrative review’s qualitative “neuromodulation works” implies effect sizes without extracting numeric outcomes is not defensible; it breaks the required input-data chain for meta-analysis.
Treating all neuropathic pain as interchangeable in effect-size pooling is a likely mismatch; DPN-specific mechanisms and staging can change responsiveness, so pooling without stratification would mislead.
Explore by Goal
Quick Explanation
Long Explanation
Top Data Sources
Ask a Follow-Up
Key Insight
Keep Exploring
Analysis 
Hypothesis Graveyard
Potential Experiments
Discussion